NDC 55111-0654-01
Sirolimus 2 mg/1 TABLET
Available — 2-Day Shipping
NDC
55111-0654-01
Generic Name
Sirolimus
Brand Name
Sirolimus
Strength
2 mg/1
Dosage Form
TABLET
Route
ORAL
Package Size
—
Labeler
Dr. Reddy's Laboratories Limited
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE Sirolimus is an mTOR inhibitor immunosuppressant indicated for the prophylaxis of organ rejection in patients aged ≥13 years receiving renal transplants: Patients at low-to moderate-immunologic risk: Use initially with cyclosporine (CsA) and corticosteroids. CsA withdrawal is recommended 2 to 4 months after transplantation ( 1.1 ). Patients at high-immunologic risk: Use in combination with CsA and corticosteroids for the first 12 months following transplantation (1.1) . S…
Source: FDA. For professional use only. Not a substitute for prescribing information.
View Product Detail →
See full specifications, request 2-day shipping, and create account to view pricing
All Sirolimus Strengths & Forms →
Compare all available NDC codes, strengths, and manufacturers
Other Sirolimus NDC Codes
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 55111-0654-01 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).